The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P.
 
Carol Aghajanian
No Relationships to Disclose
 
Virginia L. Filiaci
No Relationships to Disclose
 
Don S. Dizon
Employment - UpToDate
Consulting or Advisory Role - UpToDate
Research Funding - Aeterna Zentaris (Inst); GlaxoSmithKline (Inst)
 
Jay Carlson
No Relationships to Disclose
 
Matthew A. Powell
Consulting or Advisory Role - Arno Therapeutics; Eisai; Roche/Genentech
Speakers' Bureau - Genentech/Roche
 
Angeles Alvarez Secord
Consulting or Advisory Role - Boehringer Ingelheim; Endocyte; Genentech; GlaxoSmithKline; Janssen
Research Funding - Astellas Pharma; Astex Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Endocyte; Genentech; Incyte; Morphotek; Precision Therapeutics; Sanofi; Tesaro
 
Krishnansu Sujata Tewari
Honoraria - Advaxis
Consulting or Advisory Role - Advaxis; Caris Life Sciences; Genentech/Roche
Speakers' Bureau - Vermillion
Research Funding - Amgen (Inst); Endocyte (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
David Bender
No Relationships to Disclose
 
David M. O'Malley
Consulting or Advisory Role - Eisai; Janssen Oncology
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Regeneron (Inst); VentiRx (Inst)
 
Ashley Stuckey
No Relationships to Disclose
 
Jacob Rotmensch
No Relationships to Disclose
 
Douglas A. Levine
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca; Genentech/Roche; Immunogen
Travel, Accommodations, Expenses - AstraZeneca